Jonathan Perera

@stanfordmstp, prev. computational biology @broadinstitute BME @DukeU

[Jonathan Perera @jonathanjperera]

Really proud to be a part of this exciting work elucidating a key driver of GBM immunotherapy-resistance! @BillyTomski @Dukeneurosurg @DukeHealth check it out!

[Nature Communications @NatureComms]

Identification of CaMKK2 as a driver of immune-checkpoint blockade resistance in glioblastoma
https://t.co/hogUl3RAdI
#CancerResearch @natrescancer @BillyTomski @dukeresearch @DukeCancer @Dukeneurosurg

[Alejandro Buendia @abuen_dia]

Thrilled to announce alphagenome-pytorch, an accurate, readable, and careful port of AlphaGenome's architecture and weights to PyTorch. Work with @gtcaa @m_kjellberg @chriswzou @tuxinming as part of the GenomicsxAI initiative between @anshulkundaje and @pkoo562 labs.

[Billy Tomaszewski @BillyTomski]

(1/15) My thesis work is out in @NatureComms (https://t.co/B7s7zlC1sM)!
We found that neuronal CaMKK2 causes checkpoint blockade resistance and reduces survival in preclinical glioblastoma (GBM), indicating that CaMKK2 may be a therapeutic target in #GBM.